Literature DB >> 26280004

Management of Hepatocellular Carcinoma in Cirrhotic Patients with Portal Hypertension: Relevance of Hagen-Poiseuille's Law.

Gerond Lake-Bakaar1, Muneeb Ahmed1, Amy Evenson1, Alan Bonder1, Salomao Faintuch1, Vinay Sundaram1.   

Abstract

BACKGROUND: Hepatic decompensation in cirrhosis heralds an accelerated course with poor survival. An increase in hepatic venous pressure gradient (HVPG), rather than surrogate tests of liver function, appears to be the sole predictor of decompensation after surgical resection. We propose that hepatic sinusoidal walls become less elastic as cirrhosis progresses. Decompensation signals the development of increased vessel wall rigidity. The pressure-flow characteristics then become subject to Hagen-Poiseuille's law, which applies only to rigid, cylindrical vessels. Thereafter, HVPG rises exponentially (by a factor inversely proportional to the fourth power of the net radius of functional sinusoidal vessels, 1/r(4), at any given hepatic blood flow rate. This review attempts to correlate liver stiffness, risk of decompensation and outcomes from hepatocellular carcinoma (HCC) in patients with cirrhosis.
SUMMARY: We compare the complexity of autoregulation in the normal elastic liver, which has a unique dual blood supply, with that in the rigid cirrhotic liver. We also review, in the context of background liver cirrhosis, the management of HCC which is in essence, a solid mass of unorganized cells that exacerbates liver stiffness. We discuss the differential effects of various therapeutic modalities such as liver transplantation, loco-regional therapy and drugs on HCC outcomes, based on their effects on HVPG. KEY MESSAGES: Increased hepatic artery supply, or the hepatic artery buffer response, may be the only available method for autoregulation or maintenance of hepatic blood flow in the cirrhotic liver. In HCC, loco-regional therapies, including partial resection of the cirrhotic liver, can exacerbate portal hypertension by increasing blood flow within the remnant organ. We conclude that studies of HVPG reduction as part of HCC management may be beneficial and are warranted.

Entities:  

Keywords:  Hagen–Poiseuille's law; Hepatocellular carcinoma; Liver stiffness; Portal hypertension

Year:  2014        PMID: 26280004      PMCID: PMC4531425          DOI: 10.1159/000343871

Source DB:  PubMed          Journal:  Liver Cancer        ISSN: 1664-5553            Impact factor:   11.740


  81 in total

1.  Safety profile of sequential transcatheter chemoembolization with DC Bead™: results of 237 hepatocellular carcinoma (HCC) patients.

Authors:  Katerina Malagari; Mary Pomoni; Themistoklis N Spyridopoulos; Hippokratis Moschouris; Alexis Kelekis; Spyros Dourakis; Efthymia Alexopoulou; John Koskinas; Michalis Angelopoulos; John Kornezos; Anastasia Pomoni; Savvas Tandeles; Athanasios Marinis; Spyros Rizos; Dimitrios Kelekis
Journal:  Cardiovasc Intervent Radiol       Date:  2010-12-24       Impact factor: 2.740

2.  Chemoembolization for intermediate HCC: is there proof of survival benefit?

Authors:  Alejandro Forner; Josep M Llovet; Jordi Bruix
Journal:  J Hepatol       Date:  2011-10-17       Impact factor: 25.083

3.  A prospective, randomized, controlled trial of preoperative transarterial chemoembolization for resectable large hepatocellular carcinoma.

Authors:  Wei-Ping Zhou; Eric C H Lai; Ai-Jun Li; Si-Yuan Fu; Jian-Ping Zhou; Ze-Ya Pan; Wan Yee Lau; Meng-Chao Wu
Journal:  Ann Surg       Date:  2009-02       Impact factor: 12.969

Review 4.  Liver resection and transplantation in hepatocellular carcinoma.

Authors:  J Belghiti; D Fuks
Journal:  Liver Cancer       Date:  2012-09       Impact factor: 11.740

5.  Stereotactic body radiation therapy in recurrent hepatocellular carcinoma.

Authors:  Wen-Yen Huang; Yee-Min Jen; Meei-Shyuan Lee; Li-Ping Chang; Chang-Ming Chen; Kai-Hsiung Ko; Kuen-Tze Lin; Jang-Chun Lin; Hsing-Lung Chao; Chun-Shu Lin; Yu-Fu Su; Chao-Yueh Fan; Yao-Wen Chang
Journal:  Int J Radiat Oncol Biol Phys       Date:  2012-02-17       Impact factor: 7.038

Review 6.  Liver functional reserve estimation: state of the art and relevance to local treatments.

Authors:  Fotini Manizate; Spiros P Hiotis; Daniel Labow; Sasan Roayaie; Myron Schwartz
Journal:  Oncology       Date:  2010-07-08       Impact factor: 2.935

7.  Major complications after radio-frequency thermal ablation of hepatic tumors: spectrum of imaging findings.

Authors:  Hyunchul Rhim; Kwon-Ha Yoon; Jeong Min Lee; Yoonkoo Cho; June-Sik Cho; Seung Hoon Kim; Won-Jae Lee; Hyo Keun Lim; Gyoung-Jin Nam; Sang-Suk Han; Yun Hwan Kim; Cheol Min Park; Pyo Nyun Kim; Jae-Young Byun
Journal:  Radiographics       Date:  2003 Jan-Feb       Impact factor: 5.333

8.  Comparative study of resection and radiofrequency ablation in the treatment of solitary colorectal liver metastases.

Authors:  Hyuk Hur; Yong Taek Ko; Byung Soh Min; Kyung Sik Kim; Jin Sub Choi; Seung Kook Sohn; Chang Hwan Cho; Heung Kyu Ko; Jong Tai Lee; Nam Kyu Kim
Journal:  Am J Surg       Date:  2008-09-11       Impact factor: 2.565

9.  Hepatic venous pressure gradient identifies patients at risk of severe hepatitis C recurrence after liver transplantation.

Authors:  Alejandro Blasco; Xavier Forns; José A Carrión; Juan Carlos García-Pagán; Rosa Gilabert; Antoni Rimola; Rosa Miquel; Miquel Bruguera; Juan-Carlos García-Valdecasas; Jaime Bosch; Miquel Navasa
Journal:  Hepatology       Date:  2006-03       Impact factor: 17.425

10.  Molecular mechanisms underlying hepatocellular carcinoma.

Authors:  Philippe Merle; Christian Trepo
Journal:  Viruses       Date:  2009-11-09       Impact factor: 5.048

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.